Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma

J Surg Oncol. 1992 Mar;49(3):176-81. doi: 10.1002/jso.2930490310.

Abstract

Multiple immunological parameters, including total lymphocyte count, lymphocyte subpopulations (CD2+, CD19+, CD3+, CD4+ and CD8+), phytohemagglutinin (PHA) response, and natural killer (NK) activity, were measured in 66 patients with previously untreated esophageal carcinoma. The influence of preoperative treatment and/or surgical operation on the immune function were evaluated in 40 patients. The PHA response and NK activity of the patients with esophageal carcinoma were 229 +/- 103 S.I.% and 18.5 +/- 11.9% lysis, respectively, and were significantly depressed as compared with the control. The CD4+/CD8+ ratio, PHA response, and NK activity in stage IV were also significantly depressed compared to that in stages I-III. Preoperative treatment induced significant reductions in the total lymphocyte count (1,994 +/- 644 to 670 +/- 274/mm3), PHA response (219 +/- 77 to 159 +/- 59 S.I.%), and NK activity (19.7 +/- 13.2 to 11.1 +/- 10.3% lysis) as well as a significant gradual decrease in the CD4+/CD8+ ratio (2.09 +/- 1.42 to 0.69 +/- 0.48), while the surgical operation significantly influenced only the total lymphocyte count. This study demonstrates that preoperative treatment induces a more pronounced influence on the immune function than surgical operation alone, in patients with esophageal carcinoma in which the immune function is disturbed prior to these treatments.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD / immunology
  • Bleomycin / administration & dosage
  • Combined Modality Therapy
  • Esophageal Neoplasms / immunology*
  • Esophageal Neoplasms / therapy*
  • Female
  • Flow Cytometry
  • Humans
  • Hyperthermia, Induced
  • Killer Cells, Natural / immunology
  • Leukocyte Count
  • Lymphocytes / immunology
  • Male
  • Middle Aged
  • Phytohemagglutinins / immunology
  • Preoperative Care
  • Radiotherapy Dosage

Substances

  • Antigens, CD
  • Phytohemagglutinins
  • Bleomycin